BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22806177)

  • 1. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease.
    Bassim CW; Ambatipudi KS; Mays JW; Edwards DA; Swatkoski S; Fassil H; Baird K; Gucek M; Melvin JE; Pavletic SZ
    J Clin Immunol; 2012 Dec; 32(6):1390-9. PubMed ID: 22806177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease.
    Devic I; Shi M; Schubert MM; Lloid M; Izutsu KT; Pan C; Missaghi M; Morton TH; Mancl LA; Zhang J; Presland RB
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1048-55. PubMed ID: 24704387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.
    Costa-da-Silva AC; Aure MH; Dodge J; Martin D; Dhamala S; Cho M; Rose JJ; Bassim CW; Ambatipudi K; Hakim FT; Pavletic SZ; Mays JW
    iScience; 2022 Jan; 25(1):103592. PubMed ID: 35005541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral disease profiles in chronic graft versus host disease.
    Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
    J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease--a prolonged study.
    Nagler RM; Nagler A
    Cancer Invest; 2003; 21(1):34-40. PubMed ID: 12643007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease.
    Nagler RM; Nagler A
    Arch Oral Biol; 2001 Aug; 46(8):689-95. PubMed ID: 11389860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
    Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
    Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation.
    Pereira CM; de Almeida OP; Corrêa ME; Costa FF; de Souza CA; Barjas-Castro ML
    Oral Dis; 2007 May; 13(3):329-34. PubMed ID: 17448218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation.
    McGuirk J; Hao G; Hou W; Abhyankar S; Williams C; Yan W; Yuan J; Guan X; Belt R; Dejarnette S; Wieman J; Yan Y
    J Hematol Oncol; 2009 Apr; 2():17. PubMed ID: 19379511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
    Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
    PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components.
    Boer CC; Correa ME; Tenuta LM; Souza CA; Vigorito AC
    Support Care Cancer; 2015 Sep; 23(9):2561-7. PubMed ID: 25652148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.
    Imanguli MM; Atkinson JC; Mitchell SA; Avila DN; Bishop RJ; Cowen EW; Datiles MB; Hakim FT; Kleiner DE; Krumlauf MC; Pavletic SZ
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1362-9. PubMed ID: 20353829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of a protocol for shotgun proteomic analysis of saliva.
    Ventura TMDS; Ribeiro NR; Dionizio AS; Sabino IT; Buzalaf MAR
    J Appl Oral Sci; 2018 Jun; 26():e20170561. PubMed ID: 29898185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation.
    Treister NS; Woo SB; O'Holleran EW; Lehmann LE; Parsons SK; Guinan EC
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):721-31. PubMed ID: 16125643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
    Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral chronic graft-vs.-host disease characterization using the NIH scale.
    Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
    J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NanoLC-MS/MS analyses of urinary desmosine, hydroxylysylpyridinoline and lysylpyridinoline as biomarkers for chronic graft-versus-host disease.
    Boutin M; Ahmad I; Jauhiainen M; Lachapelle N; Rondeau C; Roy J; Thibault P
    Anal Chem; 2009 Nov; 81(22):9454-61. PubMed ID: 19848412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.